Phase II: percutaneous deliverable biomaterial for treating myocardial infarction
Ended Project Grant Awarded Last action
- Award ID
- R44HL108459
- Recipient
-
Ventrix Inc. UEI GZK6V6LL3SM8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $2,059,825
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- San Diego, CA 92109, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1,026,130 | |
| Amendment | $1,026,130 | |
| Amendment | $720,276 | |
| Original award | $1,339,549 |
Quick answers
Who received award R44HL108459?
R44HL108459 was awarded to Ventrix Inc. by National Institutes of Health (Department of Health and Human Services) on March 1, 2011.
How much is award R44HL108459 worth?
$2,059,825 has been obligated on R44HL108459.
Which agency awarded R44HL108459?
National Institutes of Health (Department of Health and Human Services) awarded R44HL108459, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award